Adverse drug events among children presenting to a hospital emergency department in Newfoundland and Labrador, Canada

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 2, 2010, Pages 132-140

  Sikdar, Khokan C ^a,b   Alaghehbandan, Reza ^a,b   MacDonald, Don ^a   Barrett, Brendan ^b   Collins, Kayla D ^a,b   Gadag, Veeresh ^b  

^a Newfoundland and Labrador Centre for Health Information   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Adverse drug event (ADE); Canada; Emergency department; Newfoundland; Pediatrics

Indexed keywords

ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS;

ABDOMINAL PAIN; ADOLESCENT; ADVERSE DRUG REACTION; ARTICLE; CANADA; CHILD; COMORBIDITY; CONSENSUS; DISEASE SEVERITY; EMERGENCY CARE; EMERGENCY WARD; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICATION ERROR; NAUSEA; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT; VOMITING;

ADOLESCENT; ANTI-INFECTIVE AGENTS; CANADA; CHILD; CHILD, PRESCHOOL; DRUG TOXICITY; EMERGENCY SERVICE, HOSPITAL; HUMANS; INFANT; INFANT, NEWBORN; PEDIATRICS;

EID: 76149086510     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1900     Document Type: Article

References (25)

1. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med 2004; 140: 795-801.
2. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277(4): 307-311.
3. Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med 1995; 155(18): 1949-1956.
4. Giacoia GP, Birenbaum DL, Sachs HC, Mattison DR. The newborn drug development initiative. Pediatrics 2006; 117(3): S1-S8.
5. Woods D, Thomas E, Holl J, Altman S, Brennan T. Adverse events and preventable adverse events in children. Pediatrics 2005; 115(1): 155-160.
6. Holdsworth MT, Fichtl RE, Behta M, et al. Incidence and impact of adverse drug events in pediatric inpatients. Arch Pediatr Adolesc Med 2003; 157(1): 60-65.
7. Buajordet I, Wesenberg F, Brors O, Langslet A. Adverse drug events in children during hospitalization and after discharge in a Norwegian University Hospital. Acta Paediatricia 2002; 91: 88-94.
8. Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics 2006; 118(2): 555-562.
9. Kimland E, Rane A, Ufer M, Panagiotidis G. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf 2005; 14(7): 493-499.
10. Jonville-Béra AP, Giraudeau B, Blanc P, Beau-Salinas F, Autret-Leca E. Frequency of adverse drug reactions in children: a prospective study. Br J Clin Pharmacol 2002; 53(2): 207-210.
11. Patel P, Zed PJ. Drug-related visits to the emergency department: how big is the problem? Pharmacotherapy 2002; 22(7): 915-923.
12. Sanz E, Boada J. Adverse drug reactions in pediatric outpatients. Int J Clin Pharm Res 1987; 7: 169-172.
13. Menniti-Ippolito F, Raschetti R, Da Cas R, Giaquinto C, Cantarutti L. Active monitoring of adverse drug reactions in children. Lancet 2000; 355: 1613-1614.
14. Cirko-Begovic A, Vrhovac B, Bakran I. Intensive monitoring of adverse drug reactions in infants and preschool children. Eur J Clin Pharmacol 1989; 36: 63-65.
15. Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med 2003; 348: 1556-1564.
16. Bates DW, Boyle DL, Vliet MBV, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995; 10: 199-205.
17. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. JAMA 1995; 274(1): 29-34.
18. Kozer E, Scolnik D, Macpherson A, et al. Variables associated with medication errors in pediatric emergency medicine. Pediatrics 2002; 110(4): 737-742.
19. Easton-Carter KL, Chapman CB, Brien JE. Emergency department attendances associated with drug-related problems in paediatrics. J Paediatr Child Health 2003; 39(2): 124-129.
20. Otero M, Dominguez-Gil A, Bajo A, Maderuelo JA. Charateristics associated with the ability to prevent adverse drug reactions in hospitalized patients- a comment. Pharmacotherapy 1999; 19: 1185-1187.
21. Cohen AL, Budnitz DS, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr 2008; 152(3): 416-421.
22. Selbst SM, Fein JA, Osterhoudt K, Ho W. Medication errors in a pediatric emergency department. Pediatr Emerg Care 1999; 15(1): 1-4.
23. Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Rubio E, Morales-Olivia FJ. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999; 47: 681-688.
24. Langley JM, Halperin S. Allergy to antibiotics in children: perception versus reality. Can J Infect Dis 2002; 13: 160-163.
25. Canadian Pediatric Society Infectious Disease and Immunization Committee. Antimicrobial resistance: implications for therapy of infections with common childhood pathogens. Pediatric Child Health 1996; 1: 51-55.